# Branch Therapeutics, Inc. — Form D

Branch Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-23. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-05-23
- Form: D
- Accession: 0002067625-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 1
- Date of first sale: 2025-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-547059

## Issuer

- Name: Branch Therapeutics, Inc.
- CIK: 0002067625
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
- Phone: 615-351-1950

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Sourav Banerjee | Director | Invergowrie Dundee, X0 |
| Christopher Hulme | Director | Oro Valley, AZ |
| Curtis Thorne | Director | Tucson, AZ |
| Curtis Thorne | Executive Officer | Tucson, AZ |

## More

- [CIK 2067625 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2067625&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002067625-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.